{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:08:32Z","timestamp":1751360912765,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10549-023-06908-0","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T01:00:39Z","timestamp":1679878839000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases"],"prefix":"10.1007","volume":"199","author":[{"given":"S.","family":"Chew Minmin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bacotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Anders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sambade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Deal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Trembath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"McKee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Brogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-3966","authenticated-orcid":false,"given":"A. D.","family":"Seidman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"6908_CR1","unstructured":"Cancer of the Breast (Female) - Cancer Stat Facts SEER. [cited 2022 Aug 1]. Available from:\u00a0https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html"},{"key":"6908_CR2","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","volume":"22","author":"JS Barnholtz-Sloan","year":"2004","unstructured":"Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22:2865\u20132872. https:\/\/doi.org\/10.1200\/JCO.2004.12.149","journal-title":"J Clin Oncol"},{"key":"6908_CR3","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang M, Voduc D, Speers CH, Nielsen TO, Gelmon K (2010) Metastatic Behavior of Breast Cancer Subtypes. JCO 28:3271\u20133277. https:\/\/doi.org\/10.1200\/JCO.2009.25.9820","journal-title":"JCO"},{"key":"6908_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","volume":"19","author":"C Denkert","year":"2018","unstructured":"Denkert C, von Minckwitz G, Darb-Esfahani S, Lederer B, Heppner BI et al (2018) Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol 19:40\u201350. https:\/\/doi.org\/10.1016\/S1470-2045(17)30904-X","journal-title":"Lancet Oncol"},{"key":"6908_CR5","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/cncr.28029","volume":"119","author":"R Hamilton","year":"2013","unstructured":"Hamilton R, Krauze M, Romkes M, Omolo B, Konstantinopoulos P et al (2013) Pathologic and gene expression features of metastatic melanomas to the brain (MBM). Cancer 119:2737\u20132746. https:\/\/doi.org\/10.1002\/cncr.28029","journal-title":"Cancer"},{"key":"6908_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.01.051","author":"PW Sperduto","year":"2020","unstructured":"Sperduto PW, Mesko S, Li J, Cagney D, Aizer A et al (2020) Beyond an updated graded prognostic assessment (Breast GPA): a prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today. Int J Radiat Oncol Biol Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.01.051","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6908_CR7","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science 331:1565\u20131570. https:\/\/doi.org\/10.1126\/science.1203486","journal-title":"Science"},{"key":"6908_CR8","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jocn.2010.03.031","volume":"17","author":"I Yang","year":"2010","unstructured":"Yang I, Tihan T, Han SJ, Wrensch MR, Wiencke J, Sughrue ME, Parsa AT (2010) CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival. J Clin Neurosci 17:1381\u20131385. https:\/\/doi.org\/10.1016\/j.jocn.2010.03.031","journal-title":"J Clin Neurosci"},{"key":"6908_CR9","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/cas.13101","volume":"107","author":"R Ogiya","year":"2016","unstructured":"Ogiya R, Niikura N, Kumaki N, Bianchini G, Kitano S et al (2016) Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients. Cancer Sci 107:1730\u20131735. https:\/\/doi.org\/10.1111\/cas.13101","journal-title":"Cancer Sci"},{"key":"6908_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13058-016-0702-8","volume":"18","author":"R Duchnowska","year":"2016","unstructured":"Duchnowska R, P\u0119ksa R, Radecka B, Mandat T, Trojanowski T et al (2016) Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1\/PD-L axis. Breast Cancer Res 18:43. https:\/\/doi.org\/10.1186\/s13058-016-0702-8","journal-title":"Breast Cancer Res"},{"key":"6908_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.humpath.2015.09.003","volume":"47","author":"A Cimino-Mathews","year":"2016","unstructured":"Cimino-Mathews A, Thompson E, Taube JM, Ye X, Lu Y et al (2016) PD-L1 (B7\u2013H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas. Hum Pathol 47:52\u201363. https:\/\/doi.org\/10.1016\/j.humpath.2015.09.003","journal-title":"Hum Pathol"},{"issue":"8","key":"6908_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1080\/15384047.2019.1595282","volume":"20","author":"X Zhu","year":"2019","unstructured":"Zhu X, Zhang Q, Wang D, Liu C, Han B, Yang JM (2019) Expression of PD-L1 attenuates the positive impacts of high-level tumor-infiltrating lymphocytes on prognosis of triple-negative breast cancer. Cancer Biol Ther 20(8):1105\u20131112. https:\/\/doi.org\/10.1080\/15384047.2019.1595282","journal-title":"Cancer Biol Ther"},{"key":"6908_CR13","doi-asserted-by":"publisher","first-page":"40836","DOI":"10.18632\/oncotarget.5696","volume":"6","author":"PN Harter","year":"2015","unstructured":"Harter PN, Bernatz S, Scholz A, Zeiner PS, Zinke J et al (2015) Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1\/PD-L1 immune checkpoints in human brain metastases. Oncotarget 6:40836\u201340849. https:\/\/doi.org\/10.18632\/oncotarget.5696","journal-title":"Oncotarget"},{"key":"6908_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1179\/016164105X49463a","volume":"27","author":"WJ Streit","year":"2005","unstructured":"Streit WJ, Conde JR, Fendrick SE, Flanary BE, Mariani CL (2005) Role of microglia in the central nervous system\u2019s immune response. Neurol Res 27:685\u2013691. https:\/\/doi.org\/10.1179\/016164105X49463a","journal-title":"Neurol Res"},{"key":"6908_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fonc.2017.00298","volume":"7","author":"D Wasilewski","year":"2017","unstructured":"Wasilewski D, Priego N, Fustero-Torre C, Valiente M (2017) Reactive astrocytes in brain metastasis. Front Oncol 7:298. https:\/\/doi.org\/10.3389\/fonc.2017.00298","journal-title":"Front Oncol"},{"key":"6908_CR16","doi-asserted-by":"publisher","DOI":"10.1227\/01.neu.0000119576.76193.b8","author":"AF Samdani","year":"2004","unstructured":"Samdani AF, Kuchner EB, Rhines L, Adamson DC, Lawson C, Tyler B, Brem H, Dawson VL, Dawson TM (2004) Astroglia induce cytotoxic effects on brain tumors via a nitric oxide-dependent pathway both in vitro and in vivo. Neurosurgery. https:\/\/doi.org\/10.1227\/01.neu.0000119576.76193.b8","journal-title":"Neurosurgery"},{"key":"6908_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10549-019-05211-1","volume":"176","author":"MJ Sambade","year":"2019","unstructured":"Sambade MJ, Prince G, Deal AM, Trembath D, McKee M et al (2019) Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases. Breast Cancer Res Treat 176:321\u2013328. https:\/\/doi.org\/10.1007\/s10549-019-05211-1","journal-title":"Breast Cancer Res Treat"},{"key":"6908_CR18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10585-008-9193-z","volume":"25","author":"DP Fitzgerald","year":"2008","unstructured":"Fitzgerald DP, Palmieri D, Hua E, Hargrave E, Steeg PS et al (2008) Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization. Clin Exp Metastasis 25:799\u2013810. https:\/\/doi.org\/10.1007\/s10585-008-9193-z","journal-title":"Clin Exp Metastasis"},{"key":"6908_CR19","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1158\/0008-5472.CAN-16-0485","volume":"76","author":"H Schwartz","year":"2016","unstructured":"Schwartz H, Blacher E, Amer M, Livneh N, Abramovitz L et al (2016) Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation. Cancer Res 76:4359\u20134371. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0485","journal-title":"Cancer Res"},{"key":"6908_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/emmm.201201623","volume":"5","author":"F Xing","year":"2013","unstructured":"Xing F, Kobayashi A, Okuda H, Watabe M, Pai SK et al (2013) Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain. EMBO Mol Med 5:384\u2013396. https:\/\/doi.org\/10.1002\/emmm.201201623","journal-title":"EMBO Mol Med"},{"key":"6908_CR21","first-page":"2064","volume":"5","author":"F Teng","year":"2015","unstructured":"Teng F, Mu D, Meng X, Kong L, Zhu H, Liu S, Zhang J, Yu J (2015) Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer. Am J Cancer Res 5:2064\u20132074","journal-title":"Am J Cancer Res"},{"key":"6908_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/0284186X.2021.1989629","volume":"61","author":"T Tramm","year":"2022","unstructured":"Tramm T, Vinter H, Vahl P, \u00d6zcan D, Alsner J, Overgaard J (2022) Tumor-infiltrating lymphocytes predict improved overall survival after post-mastectomy radiotherapy: a study of the randomized DBCG82bc cohort. Acta Oncol 61:153\u2013162. https:\/\/doi.org\/10.1080\/0284186X.2021.1989629","journal-title":"Acta Oncol"},{"key":"6908_CR23","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1200\/JCO.18.02157","volume":"37","author":"A Kov\u00e1cs","year":"2019","unstructured":"Kov\u00e1cs A, Stenmark Tullberg A, Werner R\u00f6nnerman E, Holmberg E, Hartman L et al (2019) Effect of radiotherapy after breast-conserving surgery depending on the presence of tumor-infiltrating lymphocytes: a long-term follow-up of the SweBCG91RT randomized trial. J Clin Oncol 37:1179\u20131187. https:\/\/doi.org\/10.1200\/JCO.18.02157","journal-title":"J Clin Oncol"},{"key":"6908_CR24","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","volume":"379","author":"P Schmid","year":"2018","unstructured":"Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH et al (2018) Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer. N Engl J Med 379:2108\u20132121. https:\/\/doi.org\/10.1056\/NEJMoa1809615","journal-title":"N Engl J Med"},{"key":"6908_CR25","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","volume":"396","author":"J Cortes","year":"2020","unstructured":"Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA et al (2020) Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial. Lancet 396:1817\u20131828. https:\/\/doi.org\/10.1016\/S0140-6736(20)32531-9","journal-title":"Lancet"},{"key":"6908_CR26","unstructured":"Stereotactic Radiation and Nivolumab in the Management of\u00a0Metastatic Breast Cancer\u00a0Brain Metastases. [cited 2022 Aug 1]. Available from:\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03807765"},{"key":"6908_CR27","unstructured":"Atezolizumab in Combination With Pertuzumab Plus High-dose Trastuzumab for the Treatment of Central Nervous System\u00a0Metastases\u00a0in Patients With Her2-positive\u00a0Breast Cancer [cited 2022 Aug 1]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03449238"},{"key":"6908_CR28","unstructured":"Pembrolizumab And Stereotactic Radiosurgery (SRS) Of Selected\u00a0Brain Metastases\u00a0In\u00a0Breast Cancer\u00a0Patients [cited 2022 Aug 1]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03417544"},{"key":"6908_CR29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02170","author":"N Zacharakis","year":"2022","unstructured":"Zacharakis N, Huq LM, Seitter SJ, Kim SP, Gartner JJ et al (2022) Breast cancers are immunogenic: immunologic analyses and a phase ii pilot clinical trial using mutation-reactive autologous lymphocytes. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.21.02170","journal-title":"J Clin Oncol"},{"issue":"2","key":"6908_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2967\/jnumed.113.127449","volume":"55","author":"ER O'Brien","year":"2014","unstructured":"O\u2019Brien ER, Kersemans V, Tredwell M, Checa B, Serres S et al (2014) Glial activation in the early stages of brain metastasis: TSPO as a diagnostic biomarker. J Nucl Med 55(2):275\u2013280. https:\/\/doi.org\/10.2967\/jnumed.113.127449","journal-title":"J Nucl Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-06908-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-06908-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-06908-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T02:07:02Z","timestamp":1682734022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-06908-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6908"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-06908-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"4 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CKA discloses Research funding: PUMA, Lilly, Merck, Seattle Genetics, Nektar, Tesaro, G1-Therapeutics, ZION, Novartis, Pfizer, Elucida; Compensated consultant role: Genentech, Eisai, IPSEN, Seattle Genetics, Astra Zeneca, Novartis, Immunomedics, Elucida, Athenex; Royalties: UpToDate, Jones and Bartlett. The other authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki.\u00a0Ethical review and approval were waived for this study,\u00a0as this was a retrospective observational study of data obtained for clinical purposes. This study was registered under Memorial Sloan Kettering IRB waiver #WA0125-06.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patient consent was waived due\u00a0to retrospective data being collected anonymously for\u00a0a\u00a0quality improvement process that\u00a0aimed\u00a0to improve patient care and outcomes through systematic review of care against explicit criteria\u00a0and standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}